Successful Treatment of a Patient with anti-PD1 Antibody-Resistant Advanced Mucosal Melanoma with Nivolumab, Ipilimumab plus Denosumab Combination Therapy

Since the incidence of mucosal melanoma is higher in the Japanese population compared to Caucasians, and since mucosal melanoma possesses a lower mutation burden compared to cutaneous melanoma, the efficacy of anti-PD1 antibody (Ab) monotherapy for mucosal melanoma is limited. Therefore, other targe...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Case Rep Oncol
Main Authors: Fujimura, Taku, Kambayashi, Yumi, Ohuchi, Kentaro, Amagai, Ryo, Sato, Yota, Tanita, Kayo, Hashimoto, Akira, Aiba, Setsuya
Formato: Artigo
Idioma:Inglês
Publicado em: S. Karger AG 2020
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7154272/
https://ncbi.nlm.nih.gov/pubmed/32308589
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000506327
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados